| 1 |
Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263-355.
DOI
|
| 2 |
Folsom AR, Burke GL, Ballew C, Jacobs DR Jr, Haskell WL, Donahue RP, et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin. Am J Epidemiol. 1989;130:911-924.
DOI
|
| 3 |
Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007;293:1118-1128.
DOI
|
| 4 |
Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell. 1996;87:377-389.
DOI
|
| 5 |
Wu J, Qiu L, Yan WH, Cheng XQ, Wu W, Guo XZ, et al. Serum gamma-glutamyl transferase and uric acid levels are associated with impaired fasting glucose in adults from Inner Mongolia, China. BMC Public Health. 2013;13:294.
DOI
|
| 6 |
Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res. 2005;37:246-251.
DOI
|
| 7 |
Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyl transferase and diabetes-a 4 year follow-up study. Diabetologia. 2003;46:359-364.
DOI
|
| 8 |
Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2005;25:193-197.
DOI
|
| 9 |
Yunus YM, Muniandy W, Lai HI. Comparison of serum uric acid and gamma-glutamyl transpeptidase (GGT) level in obese individuals and non-obese individual. Int J Acad Res Bus Soc Sci. 2017;7:756-769.
|
| 10 |
Feig DI, Madero M, Jalal DI, Sanchez-Lozada LG, Johnson RJ. Uric acid and the origins of hypertension. J Pediatr. 2013;162:896-902.
DOI
|
| 11 |
Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005-1015.
DOI
|
| 12 |
Qin L, Yang Z, Gu H, Lu S, Shi Q, Xing Y, et al. Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovasc Disord. 2014;14:26.
DOI
|
| 13 |
Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C. Crosssectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012;41:450-457.
DOI
|
| 14 |
Shin KA. Clinical usefulness of serum uric acid and resting heart rate in the diagnosis of metabolic syndrome in Korean adults. Biomedical Science Letters. 2017;23:118-127.
DOI
|
| 15 |
Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290:625-631.
DOI
|
| 16 |
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007;293:584-596.
DOI
|
| 17 |
Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350:1220-1234.
DOI
|
| 18 |
WHO; IASO; IOTF. The Asia-Pacific perspective: redefining obesity and its treatment [Internet]. Sydney: Australia; 2000 [cited 2018 September 10]. Available from: http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf.
|
| 19 |
Jalanko H, Ranta T, Lehtonen E, Ruoslahti E. Gamma-glutamyl transpeptidase in human amniotic fluid and in fetal tissues. Clin Chim Acta. 1983;134:337-346.
DOI
|
| 20 |
Kang DH. Does hyperuricemia play a causative role in the development and/or aggravation of renal, cardiovascular and metabolic disease? Korean J Med. 2011;80:524-528.
|
| 21 |
Aksakal E, Tanboga IH, Kurt M, Kaygin MA, Kaya A, Isik T, et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis. 2012;221:596-601.
DOI
|
| 22 |
Dogan A, Icli A, Aksoy F, Varol E, Erdogan D, Ozaydin M, et al. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events. Coron Artery Dis. 2012;23:39-44.
DOI
|
| 23 |
Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum gamma- glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J Clin Endocrinol Metab. 2006;91:1419-1422.
DOI
|
| 24 |
Akpek M, Elcik D, Kalay N, Yarlioglues M, Dogdu O, Sahin O, et al. The prognostic value of serum gamma-glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology. 2012;63:579-585.
DOI
|
| 25 |
Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005;20:1825-1832.
DOI
|
| 26 |
Lee KS, Kim KH, Cho YC. Prevalence of fatty liver and its association with indices of obesity, liver function and hyperlipidemia among adult males. J Korea Acad Industr Coop Soc. 2009;10:1414-1423.
DOI
|
| 27 |
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844-1850.
DOI
|
| 28 |
Yokoyama H, Hirose H, Moriya S, Saito I. Significant correlation between insulin resistance and serum gamma-glutamyl transpeptidase (gamma-GTP) activity in non-drinkers. Alcohol Clin Exp Res. 2002;26(8 Suppl):91-94.
|
| 29 |
Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-1821.
DOI
|
| 30 |
Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism. 2006;55:1293-1301.
DOI
|
| 31 |
Ya Z, Fei L, Yue Z, Dan L, Neng-Bo L, Yi L, et al. Association between serum gamma-glutamyl transferase and serum uric acid levels in Chinese females: a cross-sectional study. Endocr Res. 2017;42:296-301.
DOI
|
| 32 |
Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS One. 2018;13:e0206850.
DOI
|
| 33 |
Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288:27138-27149.
DOI
|
| 34 |
Hong SJ, Kim YS, Kim HS. Prevalence and clinical features of hyperuricemia in Gwangju and Jeonnam territories. J Rheum Dis. 2012;19:138-146.
DOI
|
| 35 |
Kim MS, Moon YT, Kim MS. The relationship between obesity and the risk factors of urolithiasis. Korean J Urol. 2007;48:505-511.
DOI
|
| 36 |
Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555-563.
DOI
|
| 37 |
Yano K, Rhoads G, Kagan A. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis. 1977;30:171-184.
DOI
|
| 38 |
Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61:225-232.
DOI
|
| 39 |
Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008;54:273-284.
DOI
|
| 40 |
Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 2012;17:656-669.
DOI
|
webmaster
